Medicare expenditures associated with diabetes and diabetic retinopathy

Retina

Volumn 29, Issue 2, 2009, Pages 199-206

  Schmier, Jordana K ^a,d   Covert, David W ^b   Lau, Edmund C ^a   Matthews, G Philip ^c  

^a EXPONENT INC   (United States)

^b ALCON RESEARCH LTD   (United States)

^c Vision Quest   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE DISTRIBUTION; AGED; ARTICLE; CATARACT; CATARACT EXTRACTION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DISEASE COURSE; EYE CARE; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICARE; RACE DIFFERENCE; RETINA MACULA DEGENERATION; RETROSPECTIVE STUDY; SEX DIFFERENCE; UNITED STATES; CASE CONTROL STUDY; COST; ECONOMICS; ELDERLY CARE; STATISTICS; UTILIZATION REVIEW;

AGED; CASE-CONTROL STUDIES; COSTS AND COST ANALYSIS; DIABETES MELLITUS; DIABETIC RETINOPATHY; FEMALE; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SERVICES FOR THE AGED; HUMANS; MALE; MEDICARE; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 63249107613     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181884f2d     Document Type: Article

References (29)

1. National Center for Chronic Disease Prevention and Health Promotion. National Diabetes Fact Sheet. Available at: http:// www.cdc.gov/diabetes/pubs/ estimates.htm. Accessed June 7, 2007.
2. Narayan KM, Boyle JP, Geiss LS, Saaddine JB, Thompson TJ. Impact of recent increase in incidence on future diabetes burden: U.S., 2005-2050. Diabetes Care 2006;29:2114-2116.
3. Ballesta M, Carral F, Olveira G, Giron JA, Aguilar M. Economic cost associated with type II diabetes in Spanish patients. Eur J Health Econ 2006;7:270-275.
4. Schmitt-Koopmann I, Schwenkglenks M, Spinas GA, Szucs TD. Direct medical costs of type 2 diabetes and its complications in Switzerland. Eur J Public Health 2004;14:3-9.
5. Guo JJ, Gibson JT, Gropper DM, Oswald SL, Barker KN. Empiric investigation on direct costs-of-illness and healthcare utilization of Medicaid patients with diabetes mellitus. Am J Manag Care 1998;4:1433-1446.
6. Barcelo A, Aedo C, Rajpathak S, Robles S. The cost of diabetes in Latin America and the Caribbean. Bull World Health Organ 2003;81:19 -27.
7. Oliva J, Lobo F, Molina B, Monereo S. Direct health care costs of diabetic patients in Spain. Diabetes Care 2004;27:2616- 2621.
8. Williams R, Van Gaal L, Lucioni C. Assessing the impact of complications on the costs of type II diabetes. Diabetologia 2002;45:S13-S17.
9. Bhattacharyya SK, Else BA. Medical costs of managed care in patients with type 2 diabetes mellitus. Clin Ther 1999;21: 2131-2142.
10. Koster I, von Ferber L, Ihle P, Schubert I, Hauner H. The cost burden of diabetes mellitus: the evidence from Germany-the CoDiM Study. Diabetologia 2006;49:1498-1504.
11. Morsanutto A, Berto P, Lopatriello S, et al. Major complications have an impact on total annual medical cost of diabetes: results of a database analysis. J Diabetes Complications 2006; 20:163-169.
12. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-932.
13. Rein DB, Zhang P, Wirth KE, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 2006;124:1754-1760.
14. Frick KD, Gower EW, Kempen JH, Wolff JL. Economic impact of visual impairment and blindness in the United States. Arch Ophthalmol 2007;125:544-550.
15. Javitt JC, Zhou Z, Willke RJ. Association between vision loss and higher medical care costs in Medicare beneficiaries costs are greater for those with progressive vision loss. Ophthalmology 2007;114:238-245.
16. Salm M, Belsky D, Sloan FA. Trends in cost of major eye diseases to Medicare, 1991 to 2000. Am J Ophthalmol 2006; 142:976-982.
17. Bureau of Labor Statistics. Consumer price index - all urban consumers. Available at: http://data.bls.gov/cgi-bin/surveymost. Accessed June 7, 2007.
18. Centers for Disease Control and Prevention (CDC). Correctable visual impairment among persons with diabetes - United States, 1999-2004. MMWR Morb Mortal Wkly Rep 2006;55: 1169-1172.
19. Vu HT, Keeffe JE, McCarty CA, Taylor HR. Impact of unilateral and bilateral vision loss on quality of life. Br J Ophthalmol 2005;89:360-363.
20. Chia EM, Mitchell P, Rochtchina E, Foran S, Wang JJ. Unilateral visual impairment and health related quality of life: the Blue Mountains Eye Study. Br J Ophthalmol 2003;87: 392-395.
21. Sharma S, Brown GC, Brown MM, et al. Converting visual acuity to utilities. Can J Ophthalmol 2000;35:267-272.
22. Brown GC. Vision and quality-of-life. Trans Am Ophthalmol Soc 1999;97:473-511.
23. Oladele CR, Barnett E. Racial/ethnic and social class differences in preventive care practices among persons with diabetes. BMC Public Health 2006;6:259.
24. Morse AR, Yatzkan E, Berberich B, Arons RR. Acute care hospital utilization by patients with visual impairment. Arch Ophthalmol 1999;117:943-949.
25. Lee SJ, McCarty CA, Taylor HR, Keeffe JE. Costs of mobile screening for diabetic retinopathy: a practical framework for rural populations. Aust J Rural Health 2001;9:186-192.
26. Prela CM, Smilie JG, McInerney MJ, Harwell TS, Helgerson SD. Direct mail intervention to increase retinal examination rates in Medicare beneficiaries with diabetes. Am J Med Qual 2000;15:257-262.
27. Javitt JC, Aiello LP, Chiang Y, Ferris FL III, Canner JK, Greenfield S. Preventive eye care in people with diabetes is cost-saving to the federal government. Implications for healthcare reform. Diabetes Care 1994;17:909-917.
28. Javitt JC, Aiello LP, Bassi LJ, Chiang YP, Canner JK. Detecting and treating retinopathy in patients with type I diabetes mellitus. Savings associated with improved implementation of current guidelines. American Academy of Ophthalmology. Ophthalmology 1991;98:1565-1573.
29. Javitt JC, Canner JK, Sommer A. Cost effectiveness of current approaches to the control of retinopathy in type I diabetics. Ophthalmology 1989;96:255-264.